vs
CUMBERLAND PHARMACEUTICALS INC（CPIX）与LCNB CORP（LCNB）财务数据对比。点击上方公司名可切换其他公司
LCNB CORP的季度营收约是CUMBERLAND PHARMACEUTICALS INC的1.7倍（$23.9M vs $13.7M），LCNB CORP净利率更高（23.7% vs -10.3%，领先34.0%），CUMBERLAND PHARMACEUTICALS INC同比增速更快（31.1% vs 5.1%），LCNB CORP自由现金流更多（$33.4M vs $3.0K），过去两年CUMBERLAND PHARMACEUTICALS INC的营收复合增速更高（26.9% vs 15.7%）
坎伯兰制药是一家专科制药企业，专注于开发、生产和商业化品牌处方药物，核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域，主要运营市场为美国，为相关医护人员与患者提供服务。
LCNB集团是总部位于美国的金融控股公司，通过旗下附属国民银行开展业务，主要为俄亥俄州区域市场的个人消费者、中小企业及本地社区机构提供零售与商业银行产品、财富管理及保险相关服务。
CPIX vs LCNB — 直观对比
营收规模更大
LCNB
是对方的1.7倍
$13.7M
营收增速更快
CPIX
高出26.0%
5.1%
净利率更高
LCNB
高出34.0%
-10.3%
自由现金流更多
LCNB
多$33.4M
$3.0K
两年增速更快
CPIX
近两年复合增速
15.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.7M | $23.9M |
| 净利润 | $-1.4M | $5.7M |
| 毛利率 | 83.6% | — |
| 营业利润率 | -10.0% | 29.2% |
| 净利率 | -10.3% | 23.7% |
| 营收同比 | 31.1% | 5.1% |
| 净利润同比 | 25.8% | -7.6% |
| 每股收益（稀释后） | $-0.09 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPIXLCNB
| Q4 25 | $13.7M | $23.9M | ||
| Q3 25 | $8.3M | $23.8M | ||
| Q2 25 | $10.8M | $22.8M | ||
| Q1 25 | $11.7M | $21.5M | ||
| Q4 24 | $10.4M | $22.7M | ||
| Q3 24 | $9.1M | $21.4M | ||
| Q2 24 | $9.8M | $19.3M | ||
| Q1 24 | $8.5M | $17.8M |
净利润CPIXLCNB
| Q4 25 | $-1.4M | $5.7M | ||
| Q3 25 | $-1.9M | $6.9M | ||
| Q2 25 | $-740.7K | $5.9M | ||
| Q1 25 | $1.3M | $4.6M | ||
| Q4 24 | $-1.9M | $6.1M | ||
| Q3 24 | $-1.5M | $4.5M | ||
| Q2 24 | $-1.1M | $925.0K | ||
| Q1 24 | $-1.9M | $1.9M |
毛利率CPIXLCNB
| Q4 25 | 83.6% | — | ||
| Q3 25 | 88.1% | — | ||
| Q2 25 | 81.4% | — | ||
| Q1 25 | 87.8% | — | ||
| Q4 24 | 81.1% | — | ||
| Q3 24 | 85.4% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.5% | — |
营业利润率CPIXLCNB
| Q4 25 | -10.0% | 29.2% | ||
| Q3 25 | -23.7% | 35.6% | ||
| Q2 25 | -6.9% | 31.6% | ||
| Q1 25 | 11.0% | 25.6% | ||
| Q4 24 | -17.7% | 32.9% | ||
| Q3 24 | -18.6% | 24.9% | ||
| Q2 24 | -10.4% | 4.9% | ||
| Q1 24 | -22.0% | 12.5% |
净利率CPIXLCNB
| Q4 25 | -10.3% | 23.7% | ||
| Q3 25 | -23.4% | 29.1% | ||
| Q2 25 | -6.8% | 26.0% | ||
| Q1 25 | 10.7% | 21.4% | ||
| Q4 24 | -18.2% | 27.0% | ||
| Q3 24 | -17.0% | 21.2% | ||
| Q2 24 | -11.0% | 4.8% | ||
| Q1 24 | -22.9% | 10.7% |
每股收益（稀释后）CPIXLCNB
| Q4 25 | $-0.09 | $0.40 | ||
| Q3 25 | $-0.13 | $0.49 | ||
| Q2 25 | $-0.05 | $0.41 | ||
| Q1 25 | $0.08 | $0.33 | ||
| Q4 24 | $-0.13 | $0.44 | ||
| Q3 24 | $-0.11 | $0.31 | ||
| Q2 24 | $-0.08 | $0.07 | ||
| Q1 24 | $-0.14 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $21.6M |
| 总债务越低越好 | — | $104.4M |
| 股东权益账面价值 | $24.9M | $273.9M |
| 总资产 | $76.8M | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.38× |
8季度趋势，按日历期对齐
现金及短期投资CPIXLCNB
| Q4 25 | $11.4M | $21.6M | ||
| Q3 25 | $15.2M | $35.9M | ||
| Q2 25 | $16.1M | $49.8M | ||
| Q1 25 | $15.1M | $37.7M | ||
| Q4 24 | $18.0M | $35.7M | ||
| Q3 24 | $17.5M | $39.4M | ||
| Q2 24 | $17.3M | $34.9M | ||
| Q1 24 | $18.5M | $33.0M |
总债务CPIXLCNB
| Q4 25 | — | $104.4M | ||
| Q3 25 | — | $104.7M | ||
| Q2 25 | — | $105.0M | ||
| Q1 25 | — | $104.6M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $155.7M | ||
| Q2 24 | — | $162.2M | ||
| Q1 24 | — | $162.6M |
股东权益CPIXLCNB
| Q4 25 | $24.9M | $273.9M | ||
| Q3 25 | $26.1M | $269.9M | ||
| Q2 25 | $28.0M | $263.5M | ||
| Q1 25 | $28.7M | $258.7M | ||
| Q4 24 | $22.9M | $253.0M | ||
| Q3 24 | $24.8M | $253.2M | ||
| Q2 24 | $26.3M | $245.2M | ||
| Q1 24 | $27.5M | $233.7M |
总资产CPIXLCNB
| Q4 25 | $76.8M | $2.2B | ||
| Q3 25 | $65.9M | $2.2B | ||
| Q2 25 | $67.9M | $2.3B | ||
| Q1 25 | $69.9M | $2.3B | ||
| Q4 24 | $75.6M | $2.3B | ||
| Q3 24 | $76.7M | $2.3B | ||
| Q2 24 | $78.5M | $2.4B | ||
| Q1 24 | $81.5M | $2.3B |
负债/权益比CPIXLCNB
| Q4 25 | — | 0.38× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0K | $34.4M |
| 自由现金流经营现金流 - 资本支出 | $3.0K | $33.4M |
| 自由现金流率自由现金流/营收 | 0.0% | 140.2% |
| 资本支出强度资本支出/营收 | 0.0% | 4.0% |
| 现金转化率经营现金流/净利润 | — | 6.08× |
| 过去12个月自由现金流最近4个季度 | $4.8M | $54.5M |
8季度趋势，按日历期对齐
经营现金流CPIXLCNB
| Q4 25 | $3.0K | $34.4M | ||
| Q3 25 | $187.2K | $14.0M | ||
| Q2 25 | $843.8K | $5.5M | ||
| Q1 25 | $3.9M | $2.2M | ||
| Q4 24 | $1.9M | $93.2M | ||
| Q3 24 | $475.5K | $11.9M | ||
| Q2 24 | $-855.7K | $54.9M | ||
| Q1 24 | $-2.1M | $-11.9M |
自由现金流CPIXLCNB
| Q4 25 | $3.0K | $33.4M | ||
| Q3 25 | $163.4K | $13.7M | ||
| Q2 25 | $817.3K | $5.2M | ||
| Q1 25 | $3.9M | $2.1M | ||
| Q4 24 | $1.9M | $89.4M | ||
| Q3 24 | $460.1K | $10.5M | ||
| Q2 24 | $-862.8K | $53.8M | ||
| Q1 24 | $-2.2M | $-12.8M |
自由现金流率CPIXLCNB
| Q4 25 | 0.0% | 140.2% | ||
| Q3 25 | 2.0% | 57.4% | ||
| Q2 25 | 7.5% | 23.0% | ||
| Q1 25 | 32.9% | 10.0% | ||
| Q4 24 | 18.2% | 394.0% | ||
| Q3 24 | 5.1% | 49.0% | ||
| Q2 24 | -8.8% | 278.6% | ||
| Q1 24 | -25.6% | -71.8% |
资本支出强度CPIXLCNB
| Q4 25 | 0.0% | 4.0% | ||
| Q3 25 | 0.3% | 1.3% | ||
| Q2 25 | 0.2% | 1.0% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 0.0% | 16.7% | ||
| Q3 24 | 0.2% | 6.7% | ||
| Q2 24 | 0.1% | 5.9% | ||
| Q1 24 | 0.5% | 4.8% |
现金转化率CPIXLCNB
| Q4 25 | — | 6.08× | ||
| Q3 25 | — | 2.02× | ||
| Q2 25 | — | 0.92× | ||
| Q1 25 | 3.10× | 0.48× | ||
| Q4 24 | — | 15.23× | ||
| Q3 24 | — | 2.63× | ||
| Q2 24 | — | 59.35× | ||
| Q1 24 | — | -6.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
